![]() The stock traded between $11.13 and $13.30 on volume of 1.87 million shares traded. (NASDAQ: RPTP) shares increased 3.93 percent to close at $13.22 a share Thursday. Shares of Ingredion have fallen approximately 2.25 percent year-to-date.įind out more about Ingredion including full access to the free equity report at: Analysts at KeyBanc have recently upgraded the company’s rating to "buy" from "hold". The stock traded between $61.32 and $63.65 on volume of 995,638 shares traded. (NYSE: INGR) shares increased 2.07 percent to close at $62.98 a share Thursday. Shares of ImmunoCellular Therapeutics have gained approximately 14.5 percent year-to-date.įind out more about ImmunoCellular Therapeutics including full access to the free equity report at: Analysts at Lazard Capital have recently initiated coverage on the company with a "buy" rating. The stock traded between $2.91 and $3.05 on volume of 566,275 shares traded. (NYSEMKT: IMUC) shares declined 0.68 percent to close at $2.91 a share Thursday. Shares of Auxilium Pharmaceuticals have fallen approximately 3.5 percent year-to-date.įind out more about Auxilium Pharmaceuticals including full access to the free equity report at: Lafferty have recently initiated coverage on the company with a "buy" rating. The stock traded between $17.64 and $18.33 on volume of 960,640 shares traded. (NASDAQ: AUXL) shares declined 0.61 percent to close at $17.88 a share Thursday. Take a few minutes to register with us free at and get exclusive access to our numerous stock reports and market updates.Īuxilium Pharmaceuticals, Inc. Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |